surmount-1 tirzepatide non-diabetic weight loss Was Associated with Improved Health-Related Quality of Life in Adults with Obesity or Overweight and Type 2 Diabetes: Results from the Phase 3 SURMOUNT-2 Trial | Diabetes Therapy 🤔Adults with type 2 diabetes

Health experts say the results are encouraging as they indicate that semaglutide may be an effective therapeutic option for treating comorbidities, and ultimately, improving peoples quality of life

The implications for HFpEF, OA, and the entire CKM spectrum are enormous

If your HbA1c level has increased at your most recent doctors visit, this could suggest that tirzepatide is not working as effectively as it once did

Cureus, 15 (10), e46510.

No evidence of carcinogenicity was seen in rats following oral administration of topiramate for 2 years at doses up to 120 mg/kg (approximately 4 to 10 times the MRHD of QSYMIA based on AUC estimates)

Mori N, Yasutake A, Hirayama K (2007) Comparative study of activities in reactive oxygen species production/defense system in mitochondria of rat brain and liver, and their susceptibility to methylmercury toxicity